These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7188519)
1. [A new secondary chemical: the purity of products]. Cernia E Ann Ist Super Sanita; 1982; 18(4):637-40. PubMed ID: 7188519 [No Abstract] [Full Text] [Related]
2. [Problems of control of polymers used in drug technology]. Krówczyński L Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635 [TBL] [Abstract][Full Text] [Related]
3. [Purity requirements for drugs]. Battaglino G Ann Ist Super Sanita; 1982; 18(4):615-20. PubMed ID: 7188516 [No Abstract] [Full Text] [Related]
4. [Criteria of purity and specifications, an essential premise to the beginning of any toxicological investigation]. Gatti GL Ann Ist Super Sanita; 1982; 18(4):641-2. PubMed ID: 7188520 [No Abstract] [Full Text] [Related]
5. [Examples of purity criteria for steroid drugs]. Cavina G; Moretti G; Alimenti R; Gallinella B; Porrà R; Valvo L Ann Ist Super Sanita; 1982; 18(4):677-80. PubMed ID: 7188524 [No Abstract] [Full Text] [Related]
6. Quality control of absolute bacteria removal filters. Pall DB Bull Parenter Drug Assoc; 1975; 29(4):192-204. PubMed ID: 1131463 [No Abstract] [Full Text] [Related]
8. [Health precautions and purity requirements of refined chemicals]. Macrì A; Salvatore G; Silano V Ann Ist Super Sanita; 1982; 18(4):621-31. PubMed ID: 7188517 [No Abstract] [Full Text] [Related]
9. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
10. Quality: an old solution to new discovery dilemmas? Volsen SG; Kent JM; Masson M Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718 [No Abstract] [Full Text] [Related]
11. [Study concept of traditional Chinese medicine quality standards]. Chen J; Chen L; An Z; Chang Z; Yuan X; Zhan Y Zhong Yao Cai; 2002 Oct; 25(10):748-50. PubMed ID: 15562726 [TBL] [Abstract][Full Text] [Related]
12. [Cause and measure of short of quality control on Chinese medicine herbs]. Chen J; Chen L; An Z; Yu X; Zhan Y Zhong Yao Cai; 2003 Jan; 26(1):43-6. PubMed ID: 12858774 [TBL] [Abstract][Full Text] [Related]
13. Expectations for process validation: industry perspectives. Francis R Dev Biol (Basel); 2003; 113():9-14. PubMed ID: 14620847 [No Abstract] [Full Text] [Related]
14. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report. World Health Organization World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973 [TBL] [Abstract][Full Text] [Related]
15. [Standards of good production. Problems of sampling]. Fontani F; Sekules G; Zanotti Gerosa A Boll Chim Farm; 1975 Feb; 114(2):57-69. PubMed ID: 1203102 [No Abstract] [Full Text] [Related]
17. The other side of process validation. Agalloco JP J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977 [No Abstract] [Full Text] [Related]
18. [Testing and quality control of drug preparations. IX. Methods of granulometric analysis of drug preparations]. Zácek H Cesk Farm; 1973 Apr; 22(3):126-9. PubMed ID: 4701739 [No Abstract] [Full Text] [Related]
19. [Bioengineering, pharmaceutical development and control of contamination: the three components of pharmaceutical engineering and their influence in advanced methods of production]. Ghirardini M; Falini R Boll Chim Farm; 1986 Sep; 125(9):328-38. PubMed ID: 3828099 [No Abstract] [Full Text] [Related]
20. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]